Evidence map›Paper›PMID 39868829›Full record

ReviewJournal of virology2025

Flow virometry: recent advancements, best practices, and future frontiers.

Claire Fernandes, Arvin T Persaud, Deepa Chaphekhar, Jonathan Burnie, Carolyn Belanger, Vera A Tang, Christina Guzzo

Abstract readReview
In one paragraph

Review in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Claire FernandesDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, Ontario, Canada.ORCID 0009-0008-1821-1953
Arvin T PersaudDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, Ontario, Canada.ORCID 0000-0003-4874-8969
Deepa ChaphekharDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, Ontario, Canada.ORCID 0009-0000-4952-863X
Jonathan BurnieDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, Ontario, Canada.
Carolyn BelangerDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, Ontario, Canada.
Vera A TangFlow Cytometry and Virometry Core Facility, Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Christina GuzzoDepartment of Biological Sciences, University of Toronto Scarborough, Toronto, Ontario, Canada.ORCID 0000-0002-3042-0976

Funding

Canadian Government | Canadian Institutes of Health Research (CIHR) PJH 175379Canadian Government | Canadian Institutes of Health Research (CIHR) PSS 185719Canadian Government | Canadian Institutes of Health Research (CIHR) PSS 501566Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC) Canada Graduate ScholarshipsCanadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2019-06442Ministry of Ontario Ontario Graduate Scholarship
6 · The paper itself

Abstract

The imperative for developing robust tools to detect, analyze, and characterize viruses has become increasingly evident as they continue to threaten human health. In this review, we focus on recent advancements in studying human viruses with flow virometry (FV), an emerging technique that has gained considerable momentum over the past 5 years. These advancements include the application of FV in viral surface phenotyping, viral protein functionality, virus sorting, vaccine development, and diagnostics. With examples illustrated using primary data from our recent studies, we demonstrate that FV is a powerful yet underutilized methodology that, when employed with best practices and experimental rigor, can be highly valuable for studying individual virion heterogeneity, virus phenotypes, and virus-antibody interactions. In this review, we also address the current challenges when performing FV studies, propose strategies to overcome these obstacles, and outline best practices for both new and experienced researchers. Finally, we discuss the promising future prospects of FV within the broader context of virology research.

Indexed as

VirologyVirus DiseasesVirusesHumansVirioncalibrated flow cytometryflow virometryhuman immunodeficiency virusnanoparticlesnanoscale flow cytometryquantitative flow virometryvaccine quality controlvirion-incorporated proteinsvirus-like particlesvirus phenotypingvirus sorting

Identifiers

PMID39868829
PMCPMC11853038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.